Chronic Hepatitis C Clinical Trials Database - Free Access to 299 Studies
Access comprehensive clinical trial information for Chronic Hepatitis C through Pure Global AI's free database. This collection includes 299 clinical trials across multiple phases including N/A, Phase 2, Phase 3. Currently, 3 trials are actively recruiting participants.
Research for Chronic Hepatitis C is being conducted in United States of America, China, France and 7+ other countries. Leading sponsors include Merck Sharp & Dohme LLC and Bristol-Myers Squibb. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Combined Ribavirin With Sofosbuvir/Velpatasvir/Voxilaprevir in Retreatment of Chronic Hepatitis C Non-responders
An Observational Cohort Study of Clinical Outcomes After Antiviral Treatment of Chronic Hepatitis C
Drug-drug Interaction Study Between HEC74647PA Capsule and HEC110114 Tablets in Healthy Subjects
The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC110114 Tablets in HCV-infected Subjects
The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC74647 in HCV-infected Subjects
Study of Telemedicine Stress Management and Lifestyle Group Intervention for HCV Patients
Metabolic Changes in Chronic HCV Patients Receiving DAAS
Untitled Trial
Observational Cohort Study of Clinical Outcomes After Antiviral Therapy for Chronic Hepatitis C
Monitoring of Hepatitis C Treatment Using Telemedicine - a Clinical Trial in Public Health System in Brazil
The Tolerability and Pharmacokinetics Study of HEC110114 Tablets in Healthy Adult Subjects
Real-world Effectiveness and Safety of Treatment With DAAs in Patients With CHC(Chronic Hepatitis C)
Untitled Trial
Untitled Trial
A Study to Investigate HCV Response Rates in Real World Patients: HEARTLAND Study
Real Life Evaluation of Efficacy and Safety of Direct Antiviral Agents (DAAs) for the Treatment of Hepatitis C Virus in Egypt
Study of Daclatasvir-based Therapy in Chinese Participants With Chronic Hepatitis C (CHC)
Study of CDI-31244 in Combination With Sofosbuvir (SOF) and Velpatasvir (VEL)
Re-treatment of HCV Following DAA Failure
Four weeks treatment for chronic hepatitis C in patients under 50 years of age with no significant liver fibrosis
Pure Global AI provides free access to 299 clinical trials studying Chronic Hepatitis C, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Merck Sharp & Dohme LLC, Bristol-Myers Squibb, AbbVie, among others.